Literature DB >> 15009697

Phase differentiation via combined EBSD and XEDS.

M M Nowell1, S I Wright.   

Abstract

Electron backscatter diffraction (EBSD) and orientation imaging microscopy have become established techniques for analysing the crystallographic microstructure of single and multiphase materials. In certain instances, however, it can be difficult and/or time intensive to differentiate phases within a material by crystallography alone. Traditionally a list of candidate phases is specified prior to data collection. The crystallographic information extracted from the diffraction patterns is then compared with the crystallographic information from these candidate phases, and a best-fit match is determined. Problems may arise when two phases have similar crystal structures. The phase differentiation process can be improved by collecting chemical information through X-ray energy-dispersive spectroscopy (XEDS) simultaneously with the crystallographic information through EBSD and then using the chemical information to pre-filter the crystallographic phase candidates. This technique improves both the overall speed of the data collection and the accuracy of the final characterization. Examples of this process and the limitations involved will be presented and discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009697     DOI: 10.1111/j.0022-2720.2004.01299.x

Source DB:  PubMed          Journal:  J Microsc        ISSN: 0022-2720            Impact factor:   1.758


  2 in total

1.  Controlled growth of hexagonal gold nanostructures during thermally induced self-assembling on Ge(001) surface.

Authors:  B R Jany; N Gauquelin; T Willhammar; M Nikiel; K H W van den Bos; A Janas; K Szajna; J Verbeeck; S Van Aert; G Van Tendeloo; F Krok
Journal:  Sci Rep       Date:  2017-02-14       Impact factor: 4.379

2.  Efficient few-shot machine learning for classification of EBSD patterns.

Authors:  Kevin Kaufmann; Hobson Lane; Xiao Liu; Kenneth S Vecchio
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.